Forxiga (dapagliflozin)

pCPA File Number: 20891
Negotiation Status:
Concluded with an LOI
Indication(s):
Diabetes Mellitus, Type 2
Sponsor/Manufacturer:
AstraZeneca Canada Inc.
CADTH Project Number:
SR0428-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: